| Long-Term Follow-Up of Intracranial Aneurysms Treated With Endovascular Coiling: Experience From One Institution. | |
| | |
MedLine Citation:
|
PMID: 22544871 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Background: Our aim was to evaluate the long-term treatment results in patients with intracranial aneurysms treated with endovascular techniques. Methods: Forty-four patients treated due to intracranial aneurysms between 1996 and 2002 were investigated with a time-of-flight sequence magnetic resonance angiography (TOF MRA). Results: Depending on the assessment, 47% to 51% of the treated aneurysms had a residual neck at the last digital subtraction angiography follow-up. There was filling of the aneurysm base (2%) in only 1 patient, whereas the remaining aneurysms were totally occluded. A TOF MRA performed 6 to 14 (mean 9.68) years after the last procedure showed a stable result in 93.9% of the treated aneurysms. There were no de novo aneurysms and previously untreated aneurysms were unchanged in size. Conclusion: Our long-term follow-up showed a stable result in previously coiled intracranial aneurysms. |
| | |
Authors:
|
Peter Lindvall; Ljubisa Borota; Richard Birgander; Per Jonasson; Per-Åke Ridderheim |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-4-27 |
Journal Detail:
|
Title: Vascular and endovascular surgery Volume: - ISSN: 1938-9116 ISO Abbreviation: - Publication Date: 2012 Apr |
Date Detail:
|
Created Date: 2012-4-30 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101136421 Medline TA: Vasc Endovascular Surg Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Technical Factors Affecting the Accuracy of Bedside IVC Filter Placement Using Intravascular Ultraso...
Next Document: Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.